https://www.alpineresearch.com/uncategorized/hello-world/2010-11-30T19:39:46+00:00https://www.alpineresearch.com/completed/trial-1-marketing-name/2011-08-23T20:48:41+00:00https://www.alpineresearch.com/completed/trial-2-marketing-name/2012-06-29T18:47:23+00:00https://www.alpineresearch.com/completed/oral-medication-to-treat-alzheimers-disease/2012-05-08T16:30:10+00:00https://www.alpineresearch.com/completed/new-post-title-post-4/2011-08-23T20:44:08+00:00https://www.alpineresearch.com/completed/marketing-title-for-post-5/2011-02-24T16:35:23+00:00https://www.alpineresearch.com/completed/completed-post-title/2011-03-24T16:13:13+00:00https://www.alpineresearch.com/completed/old-completed-trial/2011-02-24T16:28:20+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-post-herpetic-neuralgia-shinglesphn/2012-05-08T16:28:25+00:00https://www.alpineresearch.com/completed/protocol-abt-894-abbott-adhd/2011-03-24T16:22:37+00:00https://www.alpineresearch.com/completed/protocol-m03-654-abbott-multiple-sclerosis/2011-03-23T20:33:24+00:00https://www.alpineresearch.com/completed/protocol-m06-888-abbott-pediatric-adhd/2011-03-24T16:23:16+00:00https://www.alpineresearch.com/completed/protocol-m10-178-ol-abbott-pediatric-adhd/2011-03-24T16:20:14+00:00https://www.alpineresearch.com/completed/protocol-05-0-223-astellas-diabetic-neuropathy/2011-03-24T15:47:03+00:00https://www.alpineresearch.com/completed/protocol-04-av-109-avanir-painful-diabetic-neuropathy/2011-03-24T15:52:35+00:00https://www.alpineresearch.com/completed/protocol-avi-4020-14-avi-biopharma-west-nile-virus/2011-03-24T15:53:42+00:00https://www.alpineresearch.com/completed/protocol-avi-4065-20-avi-biopharma-hepatitis-c/2011-03-24T15:54:42+00:00https://www.alpineresearch.com/completed/protocol-bcx1812-211-biocryst-influenza/2011-03-24T15:55:30+00:00https://www.alpineresearch.com/completed/protocol-bcx1812-311-biocryst-influenza/2011-03-24T15:56:53+00:00https://www.alpineresearch.com/completed/protocol-c1538d-309-ad-us-cephalon-adhd/2011-03-24T16:03:58+00:00https://www.alpineresearch.com/completed/protocol-c1538d-312-ad-us-cephalon-adhd/2011-03-24T16:17:52+00:00https://www.alpineresearch.com/completed/protocol-c1538-3048-ad-us-open-label-cephalon-adhd/2011-03-24T16:17:06+00:00https://www.alpineresearch.com/completed/protocol-c6671a-302-pt-us-cephalon-post-traumatic-stress-disorder/2011-03-24T16:01:45+00:00https://www.alpineresearch.com/completed/protocol-depomed81-0045-ppd-inc-post-herpetic-neuralgia/2011-03-24T16:07:57+00:00https://www.alpineresearch.com/completed/protocol-depomed81-0052-ppd-inc-phn-open-label/2011-03-24T16:15:10+00:00https://www.alpineresearch.com/completed/protocol-e2007-a001-218-eisai-phn/2011-03-24T16:13:58+00:00https://www.alpineresearch.com/completed/protocol-e2007-g000-227-eisai-diabetic-peripheral-neuropathy/2011-03-24T16:10:28+00:00https://www.alpineresearch.com/completed/protocol-sct-md-32-forest-labs-pediatric-depression/2011-03-24T17:12:33+00:00https://www.alpineresearch.com/completed/protocol-sct-md-35-forest-labs-adult-depression/2011-03-24T17:13:06+00:00https://www.alpineresearch.com/completed/protocol-sct-md-39-forest-labs-depression/2011-03-24T17:13:39+00:00https://www.alpineresearch.com/completed/protocol-101998-gsk-migraine/2011-03-24T17:17:37+00:00https://www.alpineresearch.com/completed/protocol-1000368-gsk-major-depression-disorder/2011-03-24T17:18:16+00:00https://www.alpineresearch.com/completed/protocol-101468228-gsk-parkinsons-disease/2011-03-24T17:18:57+00:00https://www.alpineresearch.com/completed/protocol-trx103635-gsk-multiple-migraines/2011-03-24T17:20:38+00:00https://www.alpineresearch.com/completed/protocol-trx105852-gsk-menstrual-migraines/2011-03-24T17:21:15+00:00https://www.alpineresearch.com/completed/protocol-ipx056-b06-03-impax-labs-multiple-sclerosis-spasticity/2011-03-24T17:22:07+00:00https://www.alpineresearch.com/completed/protocol-39039039-afl-3001-j-j-non-valvular-atrial-fibrillation/2011-03-24T17:24:50+00:00https://www.alpineresearch.com/completed/protocol-331333-pai-3015-j-j-diabetic-peripheral-neuropathy/2011-03-24T17:24:20+00:00https://www.alpineresearch.com/completed/protocol-04-003-open-label-jazz-pharmaceuticals-adult-generalized-anxiety-disorder/2011-03-24T17:26:37+00:00https://www.alpineresearch.com/completed/protocol-04-001-jazz-pharmaceuticals-adult-generalized-anxiety-disorder/2011-03-24T17:27:28+00:00https://www.alpineresearch.com/completed/protocol-mp-1501-02-medicus-pharmaceuticals-acne-vulgaris/2011-03-24T17:28:15+00:00https://www.alpineresearch.com/completed/protocol-609-04-medivir-ab-herpes-simples-labialis/2011-03-24T17:29:03+00:00https://www.alpineresearch.com/completed/protocol-emr-62-225-merck-parkinsons-disease/2011-03-24T17:29:42+00:00https://www.alpineresearch.com/completed/protocol-emr-62-225-030-open-label-merck-parkinsons-disease/2011-03-24T17:30:23+00:00https://www.alpineresearch.com/completed/protocol-c116-neurogesx-inc-post-herpetic-neuralgia/2011-03-24T17:31:05+00:00https://www.alpineresearch.com/completed/protocol-nrp104-303-new-river-pharmaceuticals-adult-attention-deficit-hyperactive-disorder/2011-03-24T17:32:08+00:00https://www.alpineresearch.com/completed/protocol-nrp104-304-open-label-new-river-pharmaceuticals-adult-attention-deficit-hyperactive-disorder/2011-03-24T17:33:04+00:00https://www.alpineresearch.com/completed/protocol-cago178a2303-novartis-major-depressive-disorder/2011-03-24T17:33:47+00:00https://www.alpineresearch.com/completed/protocol-crit124e2305-novartis-pediatric-attention-deficit-hyperactive-disorder/2011-03-24T17:34:45+00:00https://www.alpineresearch.com/completed/protocol-a0081071-pfizer-diabetic-neuropathy/2011-03-24T17:35:57+00:00https://www.alpineresearch.com/completed/protocol-a3191165-pfizer-low-back-pain/2011-03-24T17:36:30+00:00https://www.alpineresearch.com/completed/protocol-a3191338-pfizer-chronic-low-back-pain/2011-03-24T17:37:53+00:00https://www.alpineresearch.com/completed/protocol-a6061026-pfizer-post-herpetic-neuralgia/2011-03-24T17:45:22+00:00https://www.alpineresearch.com/completed/protocol-a6061029-open-label-pfizer-post-herpetic-neuralgia/2011-03-24T17:53:19+00:00https://www.alpineresearch.com/completed/protocol-a0081071-pfizer-diabetic-peripheral-neuropathy/2011-03-24T17:54:04+00:00https://www.alpineresearch.com/completed/protocol-dac-1012-protein-design-labs-relapsing-multiple-sclerosis/2011-03-24T18:05:10+00:00https://www.alpineresearch.com/completed/protocol-efc5582-sanofi-aventis-generalized-anxiety-disorder/2011-03-24T18:06:28+00:00https://www.alpineresearch.com/completed/protocol-efc5892-sanofi-aventis-generalized-anxiety-disorder/2011-03-24T18:07:38+00:00https://www.alpineresearch.com/completed/protocol-sp906-schwarz-biosciences-migraine-prophylaxis/2011-03-24T18:08:44+00:00https://www.alpineresearch.com/completed/protocol-prx-cp-011-scirex-hypoxic-challenge/2011-03-24T18:09:51+00:00https://www.alpineresearch.com/completed/protocol-25632-serono-multiple-sclerosis/2011-03-24T19:09:03+00:00https://www.alpineresearch.com/completed/protocol-spd485-305-shire-pediatric-attention-deficit-hyperactive-disorder/2011-03-24T19:10:06+00:00https://www.alpineresearch.com/completed/protocol-spd465-301-shire-adult-attention-deficit-hyperactive-disorder/2011-03-24T19:11:09+00:00https://www.alpineresearch.com/completed/protocol-01-04-tl-375-041-takeda-chronic-insomnia/2011-03-24T19:17:15+00:00https://www.alpineresearch.com/completed/protocol-01-05-tl-375-061-takeda-insomnia-in-alzheimers-patients/2011-03-24T19:18:25+00:00https://www.alpineresearch.com/completed/protocol-mp-0201-06-tkl-research-atopic-dermatitis/2011-03-24T19:23:47+00:00https://www.alpineresearch.com/completed/protocol-ngx424m1g2001-torrey-pines-therapeutics-acute-migraine/2011-03-24T19:27:35+00:00https://www.alpineresearch.com/completed/protocol-a4091012-pfizer-chronic-low-back-pain/2011-03-24T19:28:11+00:00https://www.alpineresearch.com/completed/protocol-a4091039-open-label-chronic-low-back-pain/2011-03-24T19:28:42+00:00https://www.alpineresearch.com/completed/a4091031-pfizer-diabetic-peripheral-neuropathy/2011-03-24T19:29:14+00:00https://www.alpineresearch.com/completed/protocol-rg8-md-02-forest-labs-diabetic-peripheral-neuropathy/2011-03-24T19:30:22+00:00https://www.alpineresearch.com/completed/protocol-zx001-0901-zogenix-inc-migraine/2011-03-24T19:31:10+00:00https://www.alpineresearch.com/completed/protocol-azd2066-astra-zeneca-post-herpetic-neuralgia/2011-03-24T19:32:17+00:00https://www.alpineresearch.com/completed/protocol-f1j-us-hmgl-eli-lilly-osteoarthritis-of-the-knee/2011-03-24T19:33:01+00:00https://www.alpineresearch.com/completed/protocol-f1j-us-hmfr-eli-lilly-neuropathic-pain-in-multiple-sclerosis/2011-03-31T15:35:58+00:00https://www.alpineresearch.com/completed/protocol-109ms302-biogen-multiple-sclerosis/2011-03-31T15:37:00+00:00https://www.alpineresearch.com/completed/medication-for-painful-diabetic-peripheral-neuropathy/2012-05-08T15:59:26+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-moderate-to-severe-parkinsons-disease/2013-12-05T21:21:57+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-severe-chronic-obstructive-pulmonary-disease-copd/2012-06-29T18:53:27+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-diabetic-peripheral-neuropathy/2012-09-17T21:25:34+00:00https://www.alpineresearch.com/completed/protocol-f-av-45-a17-pet-scan-using-an-investigational-radioactive-drug-to-help-determine-the-likely-cause-of-cognitive-decline/2012-06-29T18:55:34+00:00https://www.alpineresearch.com/discontinued/upcoming-study-new-investigational-medication-for-mild-alzheimers-disease/2013-12-05T21:21:20+00:00https://www.alpineresearch.com/completed/upcoming-study-investigational-medication-for-subjects-in-early-stages-of-treatment-for-relapsing-remitting-multiple-sclerosis/2015-02-02T20:34:55+00:00https://www.alpineresearch.com/completed/upcoming-study-investigational-medication-for-pediatric-patients-with-autism-aspergers-disorder-or-pervasive-developmental-disorder/2013-12-05T21:15:32+00:00https://www.alpineresearch.com/completed/investigational-medication-for-multiple-sclerosis/2014-09-03T19:55:44+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-postherpetic-neuralgia-phnshingles/2015-02-02T20:34:16+00:00https://www.alpineresearch.com/completed/new-investigational-medication-for-patients-with-moderate-to-severe-copd-chronic-obstructive-pulmonary-disease/2013-12-05T21:13:49+00:00https://www.alpineresearch.com/completed/investigational-medication-people-relapsing-remitting-multiple-sclerosis/2022-03-31T19:44:30+00:00https://www.alpineresearch.com/completed/newly-approved-medication-multiple-sclerosis/2014-09-03T19:55:18+00:00https://www.alpineresearch.com/completed/new-study-medication-patients-secondary-progressive-multiple-sclerosis/2015-04-24T19:46:31+00:00https://www.alpineresearch.com/completed/new-investigational-medication-patients-chronic-obstructive-pulmonary-disease-history-cardiac-issues/2015-10-06T18:12:18+00:00https://www.alpineresearch.com/completed/new-oral-study-medication-patients-post-herpetic-neuralgia-phn/2013-12-05T22:00:55+00:00https://www.alpineresearch.com/completed/oral-investiational-medicinal-food-supplement-treatment-mild-moderate-alzheimers-disease/2015-07-22T17:04:13+00:00https://www.alpineresearch.com/completed/investigational-medicine-prevention-migraine-headaches/2016-12-05T22:47:56+00:00https://www.alpineresearch.com/completed/parkinsons-disease/2016-12-05T22:37:57+00:00https://www.alpineresearch.com/completed/investigational-medicine-copd-2/2016-12-05T22:37:30+00:00https://www.alpineresearch.com/completed/rheumatoid-arthritis/2016-12-05T22:36:57+00:00https://www.alpineresearch.com/completed/investigational-medicine-copd/2018-01-08T19:52:12+00:00https://www.alpineresearch.com/completed/investigational-medicine-postherpetic-neuralgia-phn/2015-10-06T18:02:08+00:00https://www.alpineresearch.com/completed/investigational-medicine-diabetic-peripheral-neuropathy-dpn/2016-12-05T22:35:21+00:00https://www.alpineresearch.com/completed/investigational-medicine-osteoarthritis-oa/2022-03-31T19:43:42+00:00https://www.alpineresearch.com/completed/treatment-for-chronic-low-back-pain/2016-11-14T19:13:42+00:00https://www.alpineresearch.com/completed/new-treatment-for-migraine-headaches/2018-07-31T18:06:11+00:00https://www.alpineresearch.com/completed/investigational-medication-moderate-severe-acne/2018-01-08T19:34:40+00:00https://www.alpineresearch.com/completed/investigational-treatment-migraines-adolescents/2019-05-03T21:26:27+00:00https://www.alpineresearch.com/completed/study-comparing-secukinumab-cosentyx-versus-adalimumab-humira-treatment-active-psoriatic-arthritis/2018-07-31T18:05:33+00:00https://www.alpineresearch.com/completed/phase-2-study-glycopyrronium-bromide-copd/2018-07-31T18:04:54+00:00https://www.alpineresearch.com/completed/new-investigational-treatment-migraine-prevention/2022-03-31T19:43:06+00:00https://www.alpineresearch.com/completed/asthma-research-study/2018-09-26T21:47:13+00:00https://www.alpineresearch.com/completed/narcolepsy-type-1-studies/2022-08-26T20:01:53+00:00https://www.alpineresearch.com/completed/idiopathic-hypersomnia-studies/2022-04-13T23:36:39+00:00https://www.alpineresearch.com/completed/observational-study-patients-parkinsons-disease/2022-03-31T19:44:41+00:00https://www.alpineresearch.com/completed/copd-studies/2024-10-29T19:31:04+00:00https://www.alpineresearch.com/completed/acute-migraine-treatment-study/2022-08-26T16:53:57+00:00https://www.alpineresearch.com/completed/idiopathic-hypersomnia-study/2024-10-29T19:30:46+00:00https://www.alpineresearch.com/completed/narcolepsy-type-1-with-cataplexy-studies/2024-10-29T18:10:26+00:00https://www.alpineresearch.com/completed/narcolepsy-type-2-study/2022-08-30T21:17:32+00:00https://www.alpineresearch.com/completed/narcolepsy-type-1-with-cataplexy/2022-08-26T19:57:14+00:00https://www.alpineresearch.com/completed/alzheimers-study/2024-10-29T19:29:04+00:00https://www.alpineresearch.com/active/a-double-blind-placebo-controlled-randomized-withdrawal-multicenter-study-of-the-efficacy-and-safety-of-ft218-in-the-treatment-of-idiopathic-hypersomnia-ih-with-an-open-label-safety-extension/2025-11-19T22:51:12+00:00https://www.alpineresearch.com/active/a-study-of-remternetug-in-early-alzheimers-disease/2025-11-19T22:51:37+00:00https://www.alpineresearch.com/active/effect-of-ly3848575-versus-placebo-in-participants-with-painful-distal-sensory-polyneuropathy/2025-11-19T22:50:54+00:00https://www.alpineresearch.com/active/efficacy-and-safety-of-tozorakimab-in-symptomatic-chronic-obstructive-pulmonary-disease-with-a-history-of-exacerbations/2025-11-19T22:56:10+00:00https://www.alpineresearch.com/active/the-purpose-of-this-study-is-to-compare-chf-5993-with-chf-1535-in-improving-lung-function-reducing-moderate-and-severe-copd-exacerbations-and-other-clinical-efficacy-and-safety-outcomes-in-the-targe/2025-11-19T22:49:59+00:00https://www.alpineresearch.com/active/sanofi-theseus-efficacy-safety-and-tolerability-study-of-lunsekimig-compared-with-placebo-in-adult-participants-with-inadequately-controlled-chronic-obstructive-pulmonary-disease-copd-characteri/2025-11-19T22:50:34+00:00https://www.alpineresearch.com/active/eli-lilly-triumph-7-obesity-overweight-chronic-low-back-pain/2025-11-19T22:49:16+00:00